Dr. Matthew McCormack
Senior Director, iCamuno Biotherapeutics
Dr. McCormack is a cell biologist with extensive experience in iPSC derivation and use for cell therapy, regenerative medicine, cell-based immuno-oncology, transcriptional and epigenetic control of stem cells, oncogene co-operation and genetic evolution.
His previous roles include post-doctoral positions at the MRC Laboratory of Molecular Biology (Cambridge, UK) and the Royal Melbourne Hospital and Laboratory Head positions at Walter and Eliza Hall Institute and Monash University. He has published over 40 papers in high profile journals including Science, New Engl J Med, J Exp Med and Blood.
EPIGENETICALLY CORRECTED REPROGRAMMING FOR IPS CELL-DERIVED THERAPIES AND DISEASE MODELING
Wednesday, June 11, 2025
6:00 PM – 6:30 PM HK Time